Precise Biometrics AB Announces Partnership with FedSolve

NOKOMIS, Fla.--(BUSINESS WIRE)--As demand for effective diagnostics and treatments for Parkinson’s Disease grows around the globe, Rainbow BioSciences (OTCBB: RBCC) is working to capitalize by helping to deliver promising new therapies to market.

MORE ON THIS TOPIC